Your browser doesn't support javascript.
loading
The role of caffeine in headache disorders.
Charles, Andrew.
Affiliation
  • Charles A; UCLA Goldberg Migraine Program Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Curr Opin Neurol ; 37(3): 289-294, 2024 06 01.
Article in En | MEDLINE | ID: mdl-38327229
ABSTRACT
PURPOSE OF REVIEW Caffeine is known to have both beneficial and adverse effects in individuals with headache disorders. This review describes recent findings regarding caffeine that are relevant to headache disorders and puts these findings into the context of clinical management. RECENT

FINDINGS:

Preclinical studies show that caffeine has complex effects on sleep, brain blood flow, and intracranial pressure that may depend on the timing of caffeine intake relative to the sleep-wake cycle. Caffeine metabolism may have significant inter-individual variation that influences its therapeutic and/or adverse effects. Caffeine has acute therapeutic benefit for some primary headache disorders. For migraine, this benefit is predominantly in milder headache without cutaneous allodynia. High levels of caffeine intake may contribute to progression of headache disorders. Caffeine-containing combination analgesics commonly cause medication overuse headache. Abrupt reduction in caffeine consumption is a trigger for migraine that may be important in situations including the hospital setting, religious and cultural fasting, and pregnancy.

SUMMARY:

There is not sufficient evidence to support universal guidelines for the use of dietary and medicinal caffeine in headache disorders. A sensible approach based upon available evidence is to limit dietary caffeine intake to moderate amounts with consistent timing before noon, and to use caffeine-containing combination analgesics infrequently for milder headache.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caffeine / Central Nervous System Stimulants Type of study: Guideline Limits: Humans Language: En Journal: Curr Opin Neurol Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caffeine / Central Nervous System Stimulants Type of study: Guideline Limits: Humans Language: En Journal: Curr Opin Neurol Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: United States